Please join us on Friday January 26  from 9-12 for this zoom workshop: 

Psychedelics: A Critical Look at the Past, Present and Future of Psychedelic Assisted Therapies with Zachary Sager, MD; Approved for 3 CE's

Investment of $90 for PPC Members and $140 for Nonmembers

**PLEASE NOTE**

Registration for this event is not through the PPC Website and can be found at the link below. Event details, CE information and policies can also be found on the event page: 

https://private-practice-colloquium-inc.ce-go.com/january-psychedelics-event#

This workshop will investigate the use of psychedelic assisted therapy for psychological distress through research results and case vignettes while reflecting on the historical use of psychedelics in indigenous cultures and their burgeoning use in 20th and 21st century medical applications. We will review the available evidence of psychedelic assisted therapy for psychiatric disorders, discuss the therapeutic framework for psychedelics as well as analyze potential risks and harms of psychedelic assisted therapy as this treatment becomes more mainstream.

Presenter Bio:

Zachary Sager, MD is an instructor in Medicine at Harvard Medical School and attending palliative medicine physician at Dana Farber Cancer Institute. Prior to completing palliative medicine fellowship, he trained as a psychiatrist and is one of less than 100 psychiatric trained palliative medicine physicians in the country. His clinical expertise focuses on the care of seriously ill individuals with comorbid psychiatric conditions at end of life, particularly at the intersection of pain, substance use and psychological trauma in the context of a life limiting illness. Dr. Sager's research focuses on the development of novel interventions for seriously ill individuals experiencing psychological distress at end of life, and he is presently the lead psychiatrist in a first of its kind study of psilocybin assisted psychotherapy for hospice patients experiencing demoralization. This study represents the first time a psychedelic drug has been given to patients at a Harvard affiliated site since the early 1960s. 

Learning Objectives:

• Discuss the historical use of psychedelics and modern applications in medical contexts.
• Explain the therapeutic framework of psychedelic assisted psychotherapy sessions.
• Identify and assess potential risks and harms of psychedelic assisted psychotherapy.

References:

Raison, C. L., Sanacora, G., Woolley, J., Heinzerling, K., Dunlop, B. W., Brown, R. T., Kakar, R., Hassman, M., Trivedi, R. P., Robison, R., Gukasyan, N., Nayak, S. M., Hu, X., O'Donnell, K. C., Kelmendi, B., Sloshower, J., Penn, A. D., Bradley, E., Kelly, D. F., Mletzko, T., … Griffiths, R. R. (2023). Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. JAMA, 330(9), 843–853. https://doi.org/10.1001/jama.2023.14530

Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., Su, Z., Corby, P., & Schmidt, B. L. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of psychopharmacology (Oxford, England), 30(12), 1165–1180. https://doi.org/10.1177/0269881116675512 

Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., ... & Griffiths, R. R. (2021). Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA psychiatry, 78(5), 481-489.

Mitchell, J. M., Ot’alora G, M., van der Kolk, B., Shannon, S., Bogenschutz, M., Gelfand, Y., ... & MAPP2 Study Collaborator Group. (2023). MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nature Medicine, 29(10), 2473-2480.

Continuing Education Policies: 

This event has been approved for 3 CEs and is co-sponsored by Ce-go for APA and NASW

This event has been approved by MaMHCA/MCEAP for 3 CEs. MEACP Authorization 23-0794 

Please see the CE-Go website for all information on CEs, policies and registration information: 

https://private-practice-colloquium-inc.ce-go.com/january-psychedelics-event#ce-information

We hope to see you there!